当前位置: 首页 > 详情页

Potential protective effects of red yeast rice in endothelial function against atherosclerotic cardiovascular disease

文献详情

资源类型:

收录情况: ◇ SCIE ◇ 统计源期刊 ◇ CSCD-C

机构: [1]Department of Cardiology, The First People's Hospital of Chenzhou, University of South China, Chenzhou 423000, China [2]Institute of Cardiovascular Disease, Key Lab for Arteriosclerology of Hunan Province, University of South China, Hengyang 421001, China [3]Department of Biochemistry and Molecular Biology, The Libin Cardiovascular Institute of Alberta, The University of Calgary, Health Sciences Center, 3330 Hospital Drive NW, Calgary T2N 4N1, Canada [4]Department of Cardiology, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang 471000, China [5]Class 2014, Medical College, University of South China, Hengyang 421001, China [6]Department of Hypertension, Beijing Anzhen Hospital of Capital Medical University, Beijing 100029, China
出处:
ISSN:

关键词: Red yeast rice Xuezhikang Atherosclerotic cardiovascular disease Endothelial cells Molecular mechanism

摘要:
Atherosclerotic cardiovascular disease (ASCVD) is the deadliest disease in the world, with endothelial injury occurring throughout the course of the disease. Therefore, improvement in endothelial function is of essential importance in the prevention of ASCVD. Red yeast rice (RYR), a healthy traditional Chinese food, has a lipid modulation function and also plays a vital role in the improvement of endothelial reactivity and cardiovascular protection; thus, it is significant in the prevention and treatment of ASCVD. This article reviews the molecular mechanisms of RYR and its related products in the improvement of endothelial function in terms of endothelial reactivity, anti-apoptosis of endothelial progenitor cells, oxidative stress alleviation and anti-inflammation.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 4 区 医学
小类 | 3 区 全科医学与补充医学 4 区 药学
最新[2023]版:
大类 | 2 区 医学
小类 | 3 区 全科医学与补充医学 3 区 药学
JCR分区:
出版当年[2017]版:
Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Q3 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 PHARMACOLOGY & PHARMACY Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Department of Cardiology, The First People's Hospital of Chenzhou, University of South China, Chenzhou 423000, China
共同第一作者:
通讯作者:
通讯机构: [6]Department of Hypertension, Beijing Anzhen Hospital of Capital Medical University, Beijing 100029, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院